Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 2 | 2 | 1 | — | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 3 | 3 | — | — | — | 5 |
Melanoma | D008545 | — | — | 4 | 2 | — | — | — | 5 |
Urinary bladder neoplasms | D001749 | — | C67 | — | 3 | — | — | — | 3 |
Esophageal squamous cell carcinoma | D000077277 | — | — | 2 | 2 | — | — | — | 3 |
Triple negative breast neoplasms | D064726 | — | — | — | 2 | — | — | — | 2 |
Malignant mesothelioma | D000086002 | — | — | — | 1 | — | — | — | 1 |
Mesothelioma | D008654 | — | C45 | — | 1 | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | — | — | — | 1 |
Glioblastoma | D005909 | EFO_0000515 | — | — | 1 | — | — | — | 1 |
Colorectal neoplasms | D015179 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lung neoplasms | D008175 | — | C34.90 | 1 | — | — | — | — | 1 |
Small cell lung carcinoma | D055752 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Gilvetmab |
INN | gilvetmab |
Description | Gilvetmab is an antibody pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL3990007 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 949NG8376D (ChemIDplus, GSRS) |